Latest updates for Bhyix
Fresh curated links around BHYIX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- BlackRock High Yield Fund Q2 2026 Commentary
- Invesco High Yield Fund Q2 2026 Commentary
- iShares iBonds 2026 Term High Yield and Income ETF declares monthly distribution of $0.0793
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
iShares iBonds 2026 Term High Yield and Income ETF declares monthly distribution of $0.0793
iShares' IYH or Invesco's PBE: Which Healthcare ETF Is the Better Long-Term Buy?
Broad diversification and lower costs favor iShares, but Invesco's concentrated biotech bet delivered 47% returns in one year—at the cost of steeper drawdowns.
Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
BBH concentrates on 25 large-cap biotech leaders, while XPH diversifies across 62 pharmaceutical holdings. Both charge 0.35% annually, but their five-year returns diverged signific...
iShares iBonds 2027 Term High Yield and Income ETF declares monthly distribution of $0.1039
BlackRock Sustainable Aware Advantage Large Cap Core Fund Q2 2026 Commentary
BANX: Premium Price, But The Right Environment For This Fund
BNY Mellon Short Term Municipal Bond Fund Q2 2026 Commentary
Blackstone Now Offers Yield Plus Growth That Is Too Big To Ignore
iShares iBonds Dec 2055 Term Treasury ETF declares monthly distribution of $0.0962
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH
VanEck's lower 0.35% expense ratio appeals to cost-conscious investors, while First Trust's $2.9 billion in assets and equal-weighted approach offer broader diversification across...
iShares iBonds Dec 2054 Term Treasury ETF declares monthly distribution of $0.0933
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.